X4 Pharmaceuticals Financial Overview
X4 Pharmaceuticals's market cap is currently $324.39M. The company's EPS TTM is $-0.69; its P/E ratio is -0.35; X4 Pharmaceuticals is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.
